Monkeypox Outbreak Now Seen Just a Few Years After FDA Vaccine Approval

Join The Conversation! | https://trialsitenews.com/
In what can only be called a coincidence, in 2019, the U.S. Food and Drug Administration (FDA) approved the Jynneos Smallpox Monkeypox Vaccine, which is live and non-replicating for the prevention of smallpox and monkeypox disease in adults aged 18 and above determined to be at high risk for these viral infections in what appears to represent the first outbreak outside of Africa now unfolding. The only current FDA-approved vaccine for the prevention of monkeypox disease anticipated the first outbreak by just a couple years as monkeypox is now under investigation in several European nations as well as America, Canada, and Australia report health authorities and local media.